Sophie Lapalu

Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A

Catherine Mollereau, Lionel Moulédous, Sophie Lapalu et al. · Molecular Pharmacology · 1999 · 78 citations

Comparison of the structure‐activity relationships of nociceptin and dynorphin A using chimeric peptides

Sophie Lapalu, Christiane Moisand, Honoré Mazarguil et al. · FEBS Letters · 1997 · 65 citations · Full text

Functional Domains, Pain Medicine, Noc/dyn Hybrid Peptides +21

Bypass Replication of the Cisplatin-d(GpG) Lesion by Calf Thymus DNA Polymerase β and Human Immunodeficiency Virus Type I Reverse Transcriptase Is Highly Mutagenic

Jean‐Sèbastien Hoffmann, Marie‐Jeanne Pillaire, David Garcia-Estefania et al. · Journal of Biological Chemistry · 1996 · 56 citations · Full text

Viral Replication, Viral Polymerase Structure, Genetics +21

Different domains of the ORL1 and κ‐opioid receptors are involved in recognition of nociceptin and dynorphin A

Sophie Lapalu, Christiane Moisand, Jean‐Luc Butour et al. · FEBS Letters · 1998 · 35 citations

Functional Consequences of Constitutively Active α2A-Adrenergic Receptor Expression in 3T3F442A Preadipocytes and Adipocytes

Sandrine Bétuing, Philippe Valet, Sophie Lapalu et al. · Biochemical and Biophysical Research Communications · 1997 · 23 citations

Molecular Pharmacology, Molecular Physiology, Signal Transduction +9